Endovascular Aneurysm Repair Devices Market Size was valued at USD 1.60 Billion in 2023. The Global Endovascular Aneurysm Repair Devices industry is projected to grow from USD 2.10 Billion in 2024 to USD 4.77 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.78% during the forecast period (2024 - 2032).
The growing aged and geriatric population is driving the need for effective and high-quality solutions from manufacturers and players in the market.
Manufacturers and competitors in the market for endovascular abdominal aortic aneurysm repair devices provide their consumers with vital and life-saving items, including gore excluder, talent abdominal stent graft, Aneurx Aaa Stent Graft system, and zenith flex. These products and solutions are used in various businesses, including clinics, hospitals, and research organizations. For instance, endospan released their off-the-shelf endovascular Nexus graft systems' 30-day and 1-year performance and safety outcomes in November 2021. These systems are intended to treat thoracic aortic lesions that involve the aortic arch. Boston Scientific Corporation signed an agreement in September 2021 to buy Devoro Medical, the developer of the WOLF Thrombectomy Platform, to expand its interventional techniques for thromboembolism, including the EkoSonic Endovascular System.
COVID-19 Impact Analysis
Due to concerns about the unique COVID-19 outbreak spreading to medical institutions, fewer people seek treatment for strokes and heart attacks. These variables may have had a negative impact on the endovascular treatment devices industry size in recent months. Despite these losses during the height of the crisis, increasing awareness of the virus's potential influence on cardiovascular health during and after the pandemic may help the sector regain traction shortly.
Some of the major and significant driving forces shaping the landscape of the endovascular abdominal aortic aneurysm repair devices market include rising demand for these devices due to increased consumption of tobacco and tobacco products, such as cigarettes, cigars, and hookah, an increase in the geriatric population, which is more prone to various endovascular ailments and health issues, and rising adoption of various endovascular repair devices. Furthermore, the growing demand for minimally invasive surgical treatments and the increasing availability of attractive reimbursement scenarios and policies are projected to drive demand in the endovascular abdominal aortic aneurysm repair devices market in the coming years.
Endovascular treatment device market trends will be propelled by rapid technological innovation and considerable advancements in minimally invasive operations between 2024 and 2032. Endovascular surgical procedures frequently treat problems such as peripheral vascular and cardiovascular disorders by using minimally invasive catheter techniques on veins and arteries. For instance, according to the Peterson-KFF Health System Tracker, healthcare spending per person in the United States in 2019 was predicted to be $10,966. These factors are expected to increase the need for endovascular treatment for heart disease and other disorders in the coming years.
The high cost of using new endovascular therapy devices, low awareness in economically underdeveloped countries, and the US's rigorous tax control requirements on medical products are projected to be important limitations in the market for endovascular therapy devices.
There are improved functional results among patients who have received endovascular therapy compared to those who have received medicinal management, and the increased illness load will create opportunities for market expansion over the predicted timeline. Furthermore, the rising prevalence of heart and circulation illnesses will drive the use of endovascular treatment for stroke and other cardiovascular conditions. Furthermore, technological advancement and growing markets will create new prospects for the market's future growth rate.
The market segmentation of endovascular aneurysm repair devices, by indication, is abdominal aortic aneurysm, thoracic aortic aneurysm, and others. The abdominal aortic aneurysm segment had the highest share in the endovascular aneurysm repair devices market growth in 2021 and is expected to continue its dominance over the estimated period. Furthermore, the thoracic aortic aneurysm segment is expected to grow at the quickest CAGR during the forecast timeframe due to a rise in the development of innovative devices for the treatment of thoracic aneurysms around the world.
The market segmented into endovascular aneurysm repair devices, by application, is infrarenal and pararenal. The infrarenal market segment held the largest market share in 2021 and is also expanding at the highest CAGR in the forecast period because of reasons such as decreased blood loss, reduced hospitalization, and loss of time for treatment completion.
By product, the market is segmented into percutaneous EVAR and others. The percutaneous EVAR category dominated the market in 2021 and is expected to grow at the fastest CAGR throughout the projected period. Percutaneous EVAR is a popular, safe, and successful treatment for repairing abdominal aortic aneurysms. In some recent trials, percutaneous access approaches have replaced the surgical cutdown frequently used to treat this condition over the common femoral arteries. Learning more about various percutaneous methods, including risks, complications, adjuncts, and alternative approaches, can help to enhance the outcomes and accessibility of EVAR.
Global Endovascular Aneurysm Repair Devices Market Share by Region, 2022 (%)
By Region, the market has been divided into North America, Europe, Asia-Pacific, and the Rest of the World. North American region accounted for the most extensive market share. Asia-Pacific will exhibit the highest CAGR during the forecast period.
North America led the market and held the largest market share in 2021. Some major contributors to North America's leading industry positioning in the market include an increase in the regional geriatric population, rapid adoption of technologically sound and next-generation devices, and rising patient awareness of the high availability of effective screening programs to facilitate the diagnosis of this disease.
The Asia-Pacific area is predicted to have the highest CAGR during the projection period. The Asia-Pacific region is expected to experience significant expansion in the market. This growth can be ascribed to the region's growing population, healthcare infrastructure and services advances, and the increasing affordability of various equipment and solutions.
The market includes tier-1, tier-2, and local players. The tier-1 and tier-2 players have reach with diverse product portfolios. Companies such as Novartis Pharmaceuticals, Hoffmann-La Roche, Principia Biopharma Inc, Argenx, Sanofi S.A., Pfizer Inc., Teligent Inc, Glaxo Smith Kline LLC, and Teva Pharmaceutical Industries dominate the market due to product differentiation, financial stability, strategic developments, and diversified regional presence. The players are concentrating on supporting research and development. Furthermore, they embrace strategic growth initiatives, such as development, product introduction, joint ventures, and partnerships, to strengthen their market position and capture an extensive customer base.
For instance, GORE EXCLUDER Conformable AAA Endoprosthesis with ACTIVE CONTROL System is a next-generation endovascular aneurysm repair (EVAR) device for the treatment of abdominal aortic aneurysms (AAA) in patients with challenging anatomy. In addition, the market had devised an effective way to approve the Zenith Dissection Endovascular System. This device, which consists of an intermediate stent-graft element and a distal bare stent component, provides surgeons with a less invasive alternative to open surgery for treating Type B descending thoracic aorta dissections.
Prominent players in The endovascular aneurysm repair devices market research include
Objectives of the Study
The objectives of the study are summarized in 5 stages. They are as mentioned below:
Endovascular Aneurysm Repair Devices Market Forecast & Size:
To identify and estimate the market size for The endovascular aneurysm repair devices report segmented by indication, site, and products by value (in US dollars). Also, to understand the consumption/ demand created by consumers in The endovascular aneurysm repair devices market forecast between 2024 and 2032.
Market Landscape and Trends:
To identify and infer the drivers, restraints, opportunities, and challenges in The endovascular aneurysm repair devices market growth
Market Influencing Factors:
To find out the factors which are affecting The endovascular aneurysm repair devices market size among consumers
Impact of COVID-19:
To identify and understand the various factors involved in the market affected by the pandemic
Company Profiling:
To provide a detailed insight into the major companies operating in the market. The profiling will include the financial health of the company in the past 2-3 years with segmental and regional revenue breakup, product offering, recent developments, SWOT analysis, and key strategies.
Intended Audience
| Report Attribute/Metric | Details |
| Market Size | 2032: USD 4.77 Billion |
| CAGR | 8.78% CAGR (2024-2032) |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2022 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Indication, Site, and Products |
| Geographies Covered | North America, Europe, Asia-Pacific, and the Rest of the World (RoW) |
| Key Vendors | Novartis Pharmaceuticals, Hoffmann-La Roche, Principia Biopharma Inc, Argenx, Sanofi S.A., Pfizer Inc., Teligent Inc, Glaxo Smith Kline LLC, and Teva Pharmaceutical Industries |
| Key Market Opportunities | Enhanced functional outcomes observed among patients who have undergone endovascular therapy |
| Key Market Drivers | Rapid technological innovation and the significant advancement in minimally invasive surgeries |
Frequently Asked Questions (FAQ) :
the endovascular aneurysm repair devices market is expected to record a CAGR 8.78% by 2032.
The endovascular aneurysm repair devices market forecast period is 2024 - 2032
The market is expected to register a CAGR of 4.90% over the forecast year, according to endovascular aneurysm repair devices market research.
Asia-Pacific is expected to register the highest CAGR during 2024 - 2032
North America held the largest share in 2023
The market size is expected to be USD 4.77 Billion by 2032.
Novartis Pharmaceuticals, Hoffmann-La Roche, Principia Biopharma Inc, Argenx, Sanofi S.A., Pfizer Inc., Teligent Inc, Glaxo Smith Kline LLC, and Teva Pharmaceutical Industries are the major companies operating in the market.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
